-transparent.png){kind=logo}
A new topical corticosteroid: fluocortin-butylester, was employed in 11 eczematous children (atopic and seborrhoeic dermatitis), with a good clinical result. These topical applications involve no significant risk of interference with the pituitary-adrenal function.
Related Publications
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
January 1977,
Arzneimittel-Forschung,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
October 1973,
Monatsschrift fur Kinderheilkunde,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
June 1980,
Masui. The Japanese journal of anesthesiology,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
December 1973,
Klinische Wochenschrift,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
November 1981,
Neurologia medico-chirurgica,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
January 1977,
Arzneimittel-Forschung,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
September 1981,
Nihon Naibunpi Gakkai zasshi,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
March 1974,
Journal de radiologie, d'electrologie, et de medecine nucleaire,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
January 1977,
Arzneimittel-Forschung,
E Favrod-Coune, and
P C Sizonenko, and
L Paunier, and
H Varonier, and
N Hunziker
January 1977,
Arzneimittel-Forschung,
